Wang X - Search Results

1

Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma.

Zhan C, Yan L, Wang L, Sun Y, Wang X, Lin Z, Zhang Y, Shi Y, Jiang W, Wang Q. Zhan C, et al. Among authors: wang x, wang l, wang q. J Thorac Dis. 2015 Aug;7(8):1398-405. doi: 10.3978/j.issn.2072-1439.2015.07.25. J Thorac Dis. 2015. PMID: 26380766 Free PMC article.

2

An individual nomogram can reliably predict tumor spread through air spaces in non-small-cell lung cancer.

Wang S, Shou H, Wen H, Wang X, Wang H, Lu C, Gu J, Xu F, Zhu Q, Wang L, Ge D. Wang S, et al. Among authors: wang x, wang h, wang l. BMC Pulm Med. 2022 May 26;22(1):209. doi: 10.1186/s12890-022-02002-1. BMC Pulm Med. 2022. PMID: 35619108 Free PMC article.

3

PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma.

Jiang D, Song Q, Wei X, Yu Z, Liu Y, Wang H, Wang X, Huang J, Su J, Hong Y, Xu Y, Xu C, Hou Y. Jiang D, et al. Among authors: wang h, wang x. Front Oncol. 2022 Jul 5;12:897527. doi: 10.3389/fonc.2022.897527. eCollection 2022. Front Oncol. 2022. PMID: 35865481 Free PMC article.

4

Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery.

Wang X, Wang H, Wang H, Huang J, Wang X, Jiang Z, Tan L, Jiang D, Hou Y. Wang X, et al. Among authors: wang h. BMC Cancer. 2021 Feb 3;21(1):111. doi: 10.1186/s12885-020-07779-0. BMC Cancer. 2021. PMID: 33535987 Free PMC article.

5

Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway.

Wang X, Gui L, Zhang Y, Zhang J, Shi J, Xu G. Wang X, et al. Int J Oncol. 2014 Apr;44(4):1099-106. doi: 10.3892/ijo.2014.2261. Epub 2014 Jan 21. Int J Oncol. 2014. PMID: 24452274 Free PMC article.

6

Identification of SMAD4-mutated pancreatic ductal adenocarcinoma using preoperative contrast-enhanced MRI and clinical characteristics.

Li Z, Wang C, Li J, Wang X, Li X, Yu T, Zhou J, Wang X, Zeng M, Sun H. Li Z, et al. Among authors: wang x, wang c. BMC Med Imaging. 2024 Dec 23;24(1):349. doi: 10.1186/s12880-024-01539-3. BMC Med Imaging. 2024. PMID: 39716095 Free PMC article.

7

MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection.

Sun HT, Zhang SL, Liu K, Zhou JJ, Wang XX, Shen TT, Song XH, Guo YL, Wang XL. Sun HT, et al. J Magn Reson Imaging. 2019 Aug;50(2):397-409. doi: 10.1002/jmri.26603. Epub 2018 Dec 27. J Magn Reson Imaging. 2019. PMID: 30589158

8

Predictive value of preoperative MRI features for the Ki-67 index in well-differentiated G1/G2 pancreatic neuroendocrine tumors.

Sun H, Zhang S, Liu K, Zhou J, Wang X, Shen T, Wang X. Sun H, et al. Among authors: wang x. Acta Radiol. 2019 Nov;60(11):1394-1404. doi: 10.1177/0284185119840212. Epub 2019 Mar 26. Acta Radiol. 2019. PMID: 30913907 No abstract available.

9

Pancreatic neuroendocrine tumors: MR imaging features preoperatively predict lymph node metastasis.

Sun H, Zhou J, Liu K, Shen T, Wang X, Wang X. Sun H, et al. Among authors: wang x. Abdom Radiol (NY). 2019 Mar;44(3):1000-1009. doi: 10.1007/s00261-018-1863-y. Abdom Radiol (NY). 2019. PMID: 30539251

10

Transforming growth factor‑β/miR‑143‑3p/cystatin B axis is a therapeutic target in human ovarian cancer.

Guan W, Wang X, Lin Q, Zhang J, Ren W, Xu G. Guan W, et al. Among authors: wang x. Int J Oncol. 2019 Jul;55(1):267-276. doi: 10.3892/ijo.2019.4815. Epub 2019 May 28. Int J Oncol. 2019. PMID: 31180557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211,284 results

Search Page

Filters